UK researchers back use of steroid inhalers during pandemic
The benefit outweighs the risks for asthma and COPD patients during the pandemic, they say
9th July 2020
Latest news
Gilead begins PhI trial of inhaled remdesivir
The inhaled formulation is being assessed for COVID-19 patients in the outpatient setting
9th July 2020
Final data on ViiV's cabotegravir show impressive HIV PrEP
The long-acting, injectable therapy was 66% more effective than daily oral tablets at preventing HIV
8th July 2020
New clinical trial platform launched to accelerate COVID-19 treatments
AGILE is a 'proof of confidence engine' designed to quickly identify the most promising compounds for treatment of COVID-19
8th July 2020
GSK links with Medicago to develop novel COVID-19 vaccine
Phase I clinical testing scheduled to begin mid-July
8th July 2020
EU nod for Lynparza in pancreatic cancer
The drug is the only PARP inhibitor approved in this disease
8th July 2020
Regeneron kicks off Phase III trial of COVID-19 antibody cocktail
This follows a positive review from the Independent Data Monitoring Committee of REGN-COV2 Phase I safety results
7th July 2020
CR UK pairs with Abcam
The partnership will develop and commercialise novel custom antibodies for cancer research
7th July 2020
UK scientists plead with PM for charity partnership fund
A £310 million cut in UK medical research investment is predicted this year
7th July 2020
Novartis banks EC approval for Enerzair Breezhaler
The product includes the first digital companion (sensor and app) that can be prescribed alongside a treatment for uncontrolled asthma in the EU
7th July 2020
NHS launches ‘Your COVID Recovery’ service
The service will help COVID-19 survivors who are still experiencing problems with breathing, mental health or other complications.
6th July 2020
Immune Regulation teams with DynPort on COVID-19 drug
The companies will jointly evaluate the potential of ILR201104 to treat COVID-19 related Acute Respiratory Distress Syndrome (ARDS)
6th July 2020
King's researchers win £1m grant for COVID-19 research
The grant, from the Huo Family Foundation, will support research into better understanding the immune response to SARS-CoV-2 infection
6th July 2020
UK study to research long-term health impact of COVID-19
The PHOSP-COVID study will support the development of new strategies for clinical and rehabilitation care
6th July 2020
Communiqué 2020 – winners announced!
The competition's first ever virtual awards ceremony racked up over 1,400 live views
3rd July 2020
